Answers are grounded in this paper and cite their sources.
Shows increased mortality and health care costs in patients with antimicrobial-resistant infections, indicating urgent need for prevention strategies.
There is an association between the development of antimicrobial resistance in Staphylococcus aureus, enterococci, and gram-negative bacilli and increases in mortality, morbidity, length of hospitalization, and cost of health care. For many patients, inadequate or delayed therapy and severe underlying disease are primarily responsible for the adverse outcomes of infections caused by antimicrobial-resistant organisms. Patients with infections due to antimicrobial-resistant organisms have higher costs (approximately 6,000-30,000 dollars) than do patients with infections due to antimicrobial-susceptible organisms; the difference in cost is even greater when patients infected with antimicrobial-resistant organisms are compared with patients without infection. Strategies to prevent nosocomial emergence and spread of antimicrobial-resistant organisms are essential.
No takes yet. Share an insight, caveat, or question.
Sara E. Cosgrove (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: